1. Monoclonal antibodies currently in Phase II and III trials for multiple myeloma. (August 2014) Authors: Donato, Francesca; Gay, Francesca; Bringhen, Sara; Troia, Rossella; Palumbo, Antonio Journal: Expert opinion on biological therapy Issue: Volume 14:Number 8(2014:Aug.) Page Start: 1127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open‐label, phase 1/2 study. (31st March 2019) Authors: Plesner, Torben; Arkenau, Hendrik‐Tobias; Gay, Francesca; Minnema, Monique C.; Boccadoro, Mario; Moreau, Philippe; Cavenagh, Jamie; Perrot, Aurore; Laubach, Jacob P.; Krejcik, Jakub; Ahmadi, Tahamtan; de Boer, Carla; Chen, Diana; Chiu, Christopher; Schecter, Jordan M.; Richardson, Paul G. Journal: British journal of haematology Issue: Volume 186:Number 3(2019) Page Start: e35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Continuous therapy in standard- and high-risk newly-diagnosed multiple myeloma: A pooled analysis of 2 phase III trials. (December 2018) Authors: D'Agostino, Mattia; De Paoli, Lorenzo; Conticello, Concetta; Offidani, Massimo; Ria, Roberto; Petrucci, Maria Teresa; Spada, Stefano; Marcatti, Magda; Catalano, Lucio; Gilestro, Milena; Guglielmelli, Tommasina; Baldini, Luca; Gamberi, Barbara; Rizzi, Rita; De Sabbata, Giovanni; Di Renzo, Nicola; ... Journal: Critical reviews in oncology/hematology Issue: Volume 132(2018) Page Start: 9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study. Issue 6 (June 2020) Authors: Cavo, Michele; Gay, Francesca; Beksac, Meral; Pantani, Lucia; Petrucci, Maria Teresa; Dimopoulos, Meletios A; Dozza, Luca; van der Holt, Bronno; Zweegman, Sonja; Oliva, Stefania; van der Velden, Vincent H J; Zamagni, Elena; Palumbo, Giuseppe A; Patriarca, Francesca; Montefusco, Vittorio; Galli, M... Journal: Lancet Issue: Volume 7:Issue 6(2020) Page Start: e456 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anti-CD38 monoclonal antibodies in multiple myeloma: another cook in the kitchen?. Issue 5 (May 2020) Authors: D'Agostino, Mattia; Mina, Roberto; Gay, Francesca Journal: Lancet Issue: Volume 7:Issue 5(2020) Page Start: e355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Improving outcomes for patients with relapsed multiple myeloma: Challenges and considerations of current and emerging treatment options. (September 2021) Authors: Ramasamy, Karthik; Gay, Francesca; Weisel, Katja; Zweegman, Sonja; Mateos, Maria Victoria; Richardson, Paul Journal: Blood reviews Issue: Volume 49(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Can the dismal prognosis of patients with central nervous system plasma cell neoplasms be improved?. (August 2021) Authors: Ferrero, Dario; Bonello, Francesca; Oliva, Stefania; Gay, Francesca; Boccadoro, Mario Journal: Leukemia research Issue: Volume 107(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Antibody-drug conjugates: when chemotherapy meets immuno-oncology. Issue 11 (November 2021) Authors: Mina, Roberto; Gay, Francesca Journal: Lancet Issue: Volume 8:Issue 11(2021) Page Start: e778 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MULTIPLE MYELOMA PATIENTS UNDERGOING CARFILZOMIB: VALIDATION OF A MANAGEMENT PROTOCOL FOR CARDIOVASCULAR RISK ASSESSMENT AND A NEW SCORE FOR EVENTS PREDICTION. (April 2021) Authors: Astarita, Anna; Mingrone, Giulia; Airale, Lorenzo; Cesareo, Marco; Vallelonga, Fabrizio; Bruno, Giulia; Leone, Dario; Giordana, Carlo; Rabbia, Franco; Salvini, Marco; Gay, Francesca; Bringhen, Sara; Veglio, Franco; Milan, Alberto Journal: Journal of hypertension Issue: Volume 39(2021)e-Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network. Issue 12 (December 2021) Authors: Ludwig, Heinz; Sonneveld, Pieter; Facon, Thierry; San-Miguel, Jesus; Avet-Loiseau, Hervé; Mohty, Mohamad; Mateos, Maria-Victoria; Moreau, Philippe; Cavo, Michele; Pawlyn, Charlotte; Zweegman, Sonja; Engelhardt, Monika; Driessen, Christoph; Cook, Gordon; Dimopoulos, Melitios A; Gay, Francesca; Ein... Journal: Lancet Issue: Volume 8:Issue 12(2021) Page Start: e934 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗